Prøve GULL - Gratis
December is the right time to strike with Mark: Sudeep
The New Indian Express Bengaluru
|September 02, 2025
Ahead of his birthday, the star maps his focus on one film a year, explains why his next film must arrive by year-end despite a crowded box office, and sets his roadmap toward bigger cinema with BRB
HE much-anticipated title announcement of Kichcha Sudeepa's K47 was revealed ahead of the actor's birthday celebration on September 2. Titled Mark, the film will present the Pan-India actor in a commanding new avatar, complete with a striking hairstyle that has already caught everyone's attention. A collaboration between TG Thyagarajan's Sathya Jyothi Films and Kichcha Creatiions, Mark reunites Sudeep with director Vijay Kartikeyaa after the blockbuster success of Max. Produced by Arjun Thyagarajan and Senthil Thyagarajan, with music by Ajaneesh B. Loknath and cinematography by Shekar Chandra, Mark is expected to be the grand release to close the year.
Denne historien er fra September 02, 2025-utgaven av The New Indian Express Bengaluru.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA The New Indian Express Bengaluru
The New Indian Express Bengaluru
India, Germany intent on def ties
Two countries announce road map for joint military production, naval exercises & training
2 mins
January 13, 2026
The New Indian Express Bengaluru
'HINDI CINEMA HAS LEARNT THE WRONG LESSONS FROM HOLLYWOOD'
Vivaan Shah, who delivered an impressive performance in a brief role in Ikkis, talks about how Sriram Raghavan is an inclusive filmmaker, what he despises about current mainstream cinema, and more
3 mins
January 13, 2026
The New Indian Express Bengaluru
Trade talks back, India on Pax Silica: Gor
SIGNALLING an early effort to stabilise India-US ties that have come under strain amid tariff disputes and market jitters, Washington's new ambassador to New Delhi, Sergio Gor, on Monday said the two sides will take up the outstanding trade issues during a call on Tuesday.
1 min
January 13, 2026
The New Indian Express Bengaluru
PSLV’s third-stage fails for second time in a row
Even as AI-driven deals lifted revenues for India’s top IT firms in the December quarter, new labour codes weighed heavily on profits
1 min
January 13, 2026
The New Indian Express Bengaluru
'Quality is not linked to price'
DR Cyriac Abby Philips, clinician-scientist and president of the Mission for Ethics and Science in Health (MESH) explains the motivation behind the study, its surprising findings, and what this mean for patients and doctors alike.
1 min
January 13, 2026
The New Indian Express Bengaluru
'HINDI CINEMA HAS LEARNT THE WRONG LESSONS FROM HOLLYWOOD'
Vivaan Shah, who delivered an impressive performance in a brief role in Ikkis, talks about how Sriram Raghavan is an inclusive filmmaker, what he despises about current mainstream cinema, and more
3 mins
January 13, 2026
The New Indian Express Bengaluru
'Quality is not linked to price'
DR Cyriac Abby Philips, clinician-scientist and president of the Mission for Ethics and Science in Health (MESH) explains the motivation behind the study, its surprising findings, and what this mean for patients and doctors alike.
1 min
January 13, 2026
The New Indian Express Bengaluru
2 die in Indore due to water contamination, 9 in hospital
TWO more deaths have reportedly happened in the country’s cleanest city, Indore, due to contaminated water triggering a diarrhoea outbreak, taking the toll to 23 to date.
1 mins
January 13, 2026
The New Indian Express Bengaluru
SC to examine validity of lifelong immunity to CEC and poll commissioners
THE Supreme Court on Monday decided to examine the validity of the Parliament-enacted law giving lifelong immunity from legal proceedings to Chief Election Commissioner (CEC) and Election Commissioners (ECs).
1 min
January 13, 2026
The New Indian Express Bengaluru
INDIA FACES 2nd HIGHEST ECONOMIC BURDEN DUE TO DIABETES
NDIA faces the second highest economic burden of $11.4 trillion due to diabetes —the US bears the highest costs at $16.5 trillion, and China the third at $11 trillion, a new study has estimated.
2 mins
January 13, 2026
Listen
Translate
Change font size